Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Gridiron BioNutrients™ announces new product line of high concentration premium hemp oil to meet consumer demands

Gridiron BioNutrients
Posted on: 24 Feb 18

SPOKANE, Wash., Feb. 21, 2018 /PRNewswire/ -- Gridiron BioNutrients™ (OTC: GMVP), a nutraceutical innovator specializing in Cannabidiol ("CBD") health and wellness products to the individual, (the "Company" or "Gridiron") announced today it will be adding high concentrated premium hemp oil to its product line.

"We are excited with Gridiron's addition of a full spectrum CO2 extracted CBD that will consist of three concentrations; Silver Plus containing 18% CBD, Gold Plus containing 30% CBD and Platinum Plus containing 50% CBD will provide consumers a choice of quality CBD concentrates in various sizes. These products, like our others will contain zero THC," commented Tim Orr President of Gridiron BioNutrients™.       

About Gridiron BioNutrients™  

Gridiron is focused on the development and commercialization of high quality innovative CBD products within the health and wellness marketplace. Gridiron strives to formulate and design products that maximize the human body's potential enabling individuals to heal faster, train longer and recover quicker.

Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.   Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Gridiron BioNutrients™ (the "Company") or its management, identify forward-looking statements.  These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission.  Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Media/Investor Contact:

Tim Orr - President

Andrew Parsons

Gridiron BioNutrients™ 

866-216-4759 ext. 700

800-570-0438 ext. 0


Editor's Details

Mike Wood

Last updated on: 24/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.